Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Panacea Biotec Limited - Updates

2018-08-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

0
Panacea Biotec Limited - AGM/Book Closure

2018-08-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

0
Panacea Biotec Limited - Trading Window

2018-08-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

0
Panacea Biotec Limited - Demise

2018-07-24 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

0
Panacea Biotec Limited - Updates

2018-07-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

83
Market Live: Nifty volatile, Auto index outperforms; Infosys, HDFC twins dip

2018-06-18 moneycontrol
Shriram Mutual Fund has revised the exit load structure of Shriram Equity and Debt Opportunities Fund with immediate effect, the fund house said in an addendum.
539150 ADANIENT 532617 532538 ICLQY 531349 PNCINFRA 512599 TTNQY 532343 532662 500470 532540 UCLQY CELG YESBANK INDIGO PANACEABIO CELGZ HINDALCO ANNRY TVSMOTOR IBN HTMEDIA JETAIRWAYS UCLQF 532648 YYBKY 532822 ULTRACEMCO 539448 HNDNF ICICIBANK TTST TATASTEEL TATLY 532174 IDEA TCS DCMSHRIRAM 500440 523367

83
Market Live: Midcap underperforms Nifty; ICICI Bank top gainer on Sensex

2018-06-18 moneycontrol
Market sentiment was being dominated by trade tensions between the U.S. and China with new tariffs on the table. More than 800 Chinese goods are due to get an extra 25 percent tariff starting on July 6. As a result, China has responded with a 25 percent tariff that will also be applied to certain US products starting on the same day, reports CNBC.
539150 ADANIENT 532617 532538 ICLQY 531349 PNCINFRA 512599 TTNQY 532343 532662 500470 532540 UCLQY CELG YESBANK INDIGO PANACEABIO CELGZ HINDALCO ANNRY TVSMOTOR IBN HTMEDIA JETAIRWAYS UCLQF 532648 YYBKY 532822 ULTRACEMCO 539448 HNDNF ICICIBANK TTST TATASTEEL TATLY 532174 IDEA TCS DCMSHRIRAM 500440 523367

0
Panacea Biotec stock jumps 6% on settlement agreement with Celgene for Abraxane generic

2018-06-18 moneycontrol
Panacea Biotec share price gained 5.6 percent intraday on Monday after the company settled disputes with Celgene for Abraxane generic.
PANACEABIO 531349

56
Panacea settles patent dispute with US-based Celgene Corp

2018-06-15 livemint
New Delhi:Drug firm Panacea Biotec along with its partner Apotex has inked a pact with US-based Celgene Corporation to settle patent disputes regarding Abraxane, a drug used to treat various kinds of cancer including that of breast and lungs.
PANACEABIO CELGZ CELG 531349

0
Panacea Biotec Limited - Financial Result Updates

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

0
Panacea Biotec Limited - Outcome of Board Meeting

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

0
Panacea Biotec Limited - Disclosure under SEBI Takeover Regulations

2018-04-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PANACEABIO 531349

Related Articles

RNVA: Rennova Health Analysis and Research Report

7h - Asif

Business overview Rennova Health, Inc. (together with its subsidiaries, “Rennova”, “we” or the “Company”) is a provider of an expanding group of health care services for healthcare providers, patients and individuals. Beginning in 2018, the Company intends to focus on and operate two synergistic divisions: 1) Clinical diagnostics through its clinical laboratories; and 2) Hospital operations through its Big South Fork Medical Center, which opened on August 8, 2017, and a hospital in Jamestown Tennessee, including a doctor’s practice, the assets of which the company expect to acquire in the second quarter of 2018, pursuant to the terms of a definitive asset purchase agreement that the company entered into on January 31, 2018, as more fully discussed below. The company believe that its approach will produce a more sustainable business model and the capture of multiple revenue streams from medical providers, patients and hospital services. Management determined that because Big So...

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...